<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the effect of piperphentonamine <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> (PPTA) on <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> induced by <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion and explore the possible mechanisms </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: SD rats were randomly divided into sham-operated group, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion group (with saline injection), PPTA-treated groups (2.5, 5, 10 mg/kg) and <z:chebi fb="0" ids="31530">edaravone</z:chebi>-treated group (6 mg/kg) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo>-reperfusion injury was induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, and the agents were administrated 1 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>At 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, step-through passive avoidance test was carried out, and 24 h later IL-1β, TNF-α, caspase-3 and <z:chebi fb="24" ids="50430">HSP</z:chebi>-70 mRNA expressions in the ischemic brain tissues were measured with RT-PCR </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In the step-through passive avoidance test, the rats in the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-reperfusion group showed significantly shorter latency and more error times than those in the sham group, and these <z:hpo ids='HP_0000708'>behavioral changes</z:hpo> were improved significantly by treatments with PPTA and <z:chebi fb="0" ids="31530">edaravone</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo>-reperfusion caused significantly increased expressions of IL-1β, TNF-α, caspase-3 and <z:chebi fb="24" ids="50430">HSP</z:chebi>-70 mRNA, and these changes were obviously reversed by PPTA, but not by <z:chebi fb="0" ids="31530">edaravone</z:chebi> </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: PPTA can reverse <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> induced by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion probably by decreasing the <z:mp ids='MP_0001845'>inflammatory responses</z:mp> and cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the brain, suggesting its potential as a new therapeutic agent for improving the cognitive function following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>-reperfusion </plain></SENT>
</text></document>